Fact CheckerSign in

NCT05728840Recruiting

Virtual-reality Exercises for Alleviating Attention Deficits in Patients With Acquired Brain Injury

Source: ClinicalTrials.gov · Last updated 17 Feb 2026

Brief summary (registry, in English)

Stroke is the leading cause of long-term disability with an increasing incidence, especially in young adults. Among the cognitive difficulties following brain damage, deficits in attention are frequent and pervasive, affecting between 46% and 92% of stroke survivors. The current project targets patients with acquired brain injury, including stroke, traumatic brain injury, and brain tumor. The main objective of this study is to evaluate the use and the efficacy of a training program targeting attention and executive function difficulties, using gamified and digitized versions in virtual reality of standard cognitive exercises for patients with brain lesions.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
135 (estimated)
First submitted
26 Jan 2023
Start date
15 Feb 2023
Primary completion date
31 Jul 2026
Lead sponsor
Mindmaze SA
Diseases
Stroke
NCT number
NCT05728840

What you commit to

  • Study type: Interventional
  • Planned participants: 135
  • From 15 Feb 2023 to the primary completion date, 31 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Epilepsy
  • Major psychiatric co-morbidity
  • Major neurocognitive deficits (e.g. dementia)

Other

  • Inability or contraindications to undergo the investigated intervention
  • Incapacity to discriminate colors
  • General cognitive state preventing to understand and perform the tasks
  • Decision to not be informed of incidental findings

Who the study is looking for

  • Time from stroke onset \< 1 month
  • Objective pathological performance on at least one standardized test or subtest on attention during standard neuropsychological evaluation
  • Brain injury documented by routine neuroradiological examination (computed tomography or magnetic resonance imaging scan)
  • Able to give informed consent as documented by signature
  • Age \>= 18 years old

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Lausanne Hospitals
Coordinator of this site? Confirm its status
LausanneSwitzerlandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.